User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 7 results.
    • Speech
    Economic analysis of lipid lowering cost in Belgium
    Muls, E. VanGanse, E Closon, Marie-Christine[UCL] (1997) —
    • Speech
    Optimal Type 2 Diabetes Management Including Benchmarking and Standard Treatment. Baseline European Results
    Hermans, Michel[UCL] Muls, E.[UCL] Michel, Georges-Henry[UCL] Elisaf, M. Brotons, C. Matthys, A. (2010) 78th Congress of the European-Atherosclerosis-Society — Hamburg (Germany)
    • Journal article
    Simvastatin Use in Children
    Ducobu, J. Brasseur, D. Chaudron, JM. Deslypere, JP. Harvengt, Carl[UCL] Muls, E. Thomson, M. (1992) The Lancet — Vol. 339, no. 8807, p. 1488-1488 (1992)
    • Speech
    Cost-effectiveness of pravastatin in secondary prevention of coronary heart disease: comparison between Belgium and the United States of a projected risk model
    Muls, E. Van Ganse, E Closon, Marie-Christine[UCL] (1998) 68th Meeting of the European-Atherosclerosis-Society (EAS) — BRUGGE(Belgium)
    • Journal article
    Effect of Erythromycin On Gastric-motility in Controls and in Diabetic Gastroparesis
    Tack, Jean-Pierre[UCL] Janssens, Julien[UCL] Vantrappen, G. Peeters, T. Annese, V. Depoortere, I. Muls, E. Bouillon, R. (1992) Gastroenterology — Vol. 103, no. 1, p. 72-79 (1992)
    • Journal article
    The efficacy of atorvastatin in treating patients with hypercholesterolaemia to target LDL-cholesterol goals: the LIPI-GOAL trial
    Muls, E. De Backer, G Brohet, Christian[UCL] Heller, F. (2001) Acta Cardiologica : an international journal of cardiology — Vol. 56, no. 2, p. 109-114 (2001)
    • Journal article
    LIPI-WATCH, a Belgian/Luxembourg survey on achievement of European atherosclerosis society lipid goals
    Muls, E. De Backer, G. De Bacquer, D. Brohet, M.[UCL] Heller, F. (2000) Clinical Drug Investigation — Vol. 19, no. 3, p. 219-229 (2000)